January 18, 2024

C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

While among CHD-free individuals Lp(a) was significantly associated with incident CHD regardless of hsCRP, in participants with CHD at baseline, Lp(a) was related to recurrent CHD events only in those with residual inflammatory risk. These findings might guide adequate selection of high-risk patients for forthcoming Lp(a)-targeting compounds.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Arnold et al. (Thu,) studied this question.

synapsesocial.com/papers/69eee05fb65c86b636037fc6 https://doi.org/https://doi.org/10.1093/eurheartj/ehad867

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1From Focal Lipid Storage to Systemic Inflammation2019 · 286 citations
2Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans2016 · 657 citations
3Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). population-based reference values in an area with low incidence of cardiovascular disease2003 · 17 citations
4Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome2022 · 37 citations
5Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients2015 · 51 citations

Preguntar a la IA

Me gusta

Guardar